Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
28
09
2020
accepted:
27
06
2021
revised:
12
08
2021
pubmed:
3
8
2021
medline:
17
11
2021
entrez:
2
8
2021
Statut:
epublish
Résumé
Prompt diagnosis of acute schistosomiasis benefits the individual and provides opportunities for early public health intervention. In endemic areas schistosomiasis is usually contracted during the first 5 years of life, thus it is critical to look at how the infection manifests in this age group. The aim of this study was to describe the prodromal signs and symptoms of early schistosomiasis infection, correlate these with early disease progression and risk score to develop an easy to use clinical algorithm to identify early Schistosoma haematobium infection cases in resource limited settings. Two hundred and four, preschool age children who were lifelong residence of a schistosomiasis endemic district and at high risk of acquiring schistosomiasis were followed up from July 2019 to December 2019, during high transmission season. The children received interval and standard full clinical evaluations and laboratory investigations for schistosomiasis by clinicians blinded from their schistosomiasis infection status. Diagnosis of S. haematobium was by urine filtration collected over three consecutive days. Signs and symptoms of schistosomiasis at first examination visit were compared to follow-up visits. Signs and symptoms common on the last schistosomiasis negative visit (before a subsequent positive) were assigned as early schistosomiasis infection (ESI), after possible alternative causes were ruled out. Logistic regression identified clinical predictors. A model based score was assigned to each predictor to create a risk for every child. An algorithm was created based on the predictor risk scores and validated on a separate cohort of 537 preschool age children. Twenty-one percent (42) of the participants were negative for S. haematobium infection at baseline but turned positive at follow-up. The ESI participants at the preceding S. haematobium negative visit had the following prodromal signs and symptoms in comparison to non-ESI participants; pruritic rash adjusted odds ratio (AOR) = 21.52 (95% CI 6.38-72.66), fever AOR = 82 (95% CI 10.98-612), abdominal pain AOR = 2.6 (95% CI 1.25-5.43), pallor AOR = 4 (95% CI 1.44-11.12) and a history of facial/body swelling within the previous month AOR = 7.31 (95% CI 3.49-15.33). Furthermore 16% of the ESI group had mild normocytic anaemia, whilst 2% had moderate normocytic anaemia. A risk score model was created using a rounded integer from the relative risks ratios. The diagnostic algorithm created had a sensitivity of 81% and a specificity of 96.9%, Positive predictive value = 87.2% and NPV was 95.2%. The area under the curve for the algorithm was 0.93 (0.90-0.97) in comparison with the urine dipstick AUC = 0.58 (0.48-0.69). There was a similar appearance in the validation cohort as in the derivative cohort. This study demonstrates for the first time prodromal signs and symptoms associated with early S. haematobium infection in pre-school age children. These prodromal signs and symptoms pave way for early intervention and management, thus decreasing the harm of late diagnosis. Our algorithm has the potential to assist in risk-stratifying pre-school age children for early S. haematobium infection. Independent validation of the algorithm on another cohort is needed to assess the utility further.
Identifiants
pubmed: 34339415
doi: 10.1371/journal.pntd.0009599
pii: PNTD-D-20-01729
pmc: PMC8360514
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009599Subventions
Organisme : Department of Health
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Parasitology. 2014 Dec;141(14):1962-70
pubmed: 24679476
Br Med J. 1945 Oct 6;2(4422):453-6
pubmed: 20786321
PLoS Negl Trop Dis. 2018 Feb 8;12(2):e0006144
pubmed: 29420537
BMJ Glob Health. 2018 Mar 27;3(2):e000661
pubmed: 29616147
Lancet Infect Dis. 2018 Jun;18(6):e193-e203
pubmed: 29170089
BMC Infect Dis. 2019 Jul 22;19(1):653
pubmed: 31331269
Infect Dis Obstet Gynecol. 1995;2(5):235-8
pubmed: 18475400
Front Immunol. 2018 Nov 14;9:2635
pubmed: 30487796
Lancet. 1983 May 7;1(8332):1005-8
pubmed: 6133057
World J Gastroenterol. 2000 Feb;6(1):12-19
pubmed: 11819515
J Parasitol Res. 2012;2012:154743
pubmed: 22970345
Curr Ther Res Clin Exp. 2019 Jun 22;91:5-9
pubmed: 31372189
Trends Parasitol. 2005 Aug;21(8):386-92
pubmed: 15967725
J Infect Dis. 2007 Sep 1;196(5):659-69
pubmed: 17674306
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3014
pubmed: 25121489
Trans R Soc Trop Med Hyg. 1979;73(4):375-80
pubmed: 555062
Lancet Infect Dis. 2007 Mar;7(3):218-24
pubmed: 17317603
Infect Dis Poverty. 2018 Apr 30;7(1):41
pubmed: 29706131
Am J Trop Med Hyg. 2012 Nov;87(5):862-7
pubmed: 22987658
Adv Exp Med Biol. 2012;746:42-52
pubmed: 22639158
Antimicrob Agents Chemother. 2003 May;47(5):1487-95
pubmed: 12709312
Clin Microbiol Infect. 2010 Mar;16(3):225-31
pubmed: 20222897
J Travel Med. 2001 Mar-Apr;8(2):92-9
pubmed: 11285168
Afr Health Sci. 2014 Jun;14(2):390-6
pubmed: 25320589
Curr Opin Infect Dis. 2004 Oct;17(5):439-47
pubmed: 15353964
Med J Armed Forces India. 2010 Jul;66(3):299
pubmed: 27408327
Clin Microbiol Rev. 2015 Oct;28(4):939-67
pubmed: 26224883
Parasitology. 2009 Oct;136(12):1581-92
pubmed: 19265564
J Travel Med. 2007 Sep-Oct;14(5):334-7
pubmed: 17883465